Drug maker TaiGen Biotechnology Co (太景生技) is set to debut its shares on the Emerging Stock Market by the end of this month and plans to use the initial public offering (IPO) proceeds to finance clinical trials of its drugs, the company said yesterday.
The Cayman Island-registered company plans to issue 652 million shares, each with par value of US$0.001, said chief financial officer Max Chan (詹孟恭). The firm plans to set its IPO price before Monday next week, he said.
Founded in 2001, the company currently has three new drugs in its pipeline — Nemonnoxacin, Burixafor and TG-2349. Nemonnoxacin is an antibiotic and Burixafor is used to mobilize a leukemia patient’s stem cells and TG-2349 is used to cure hepatitis C, according to the company.
Burixafor completed the phase two clinical trials in the US, and TG-2349 is under phase one and two clinical trials in both the US and Taiwan, the company said, adding that Nemonnoxacin is currently under review for new drug application in China.
Nemonnoxacin is expected to obtain its Chinese drug permit in the first half of next year, with the patent lasting till 2029, it said.
In addition, the oral formulation of Nemonoxacin was licensed to China-based Zhejiang Medicine Co (浙江醫藥集團) for US$8 million and royalties of 7 percent to 11 percent on future sales of the drug.
The government owns 31.82 percent shares in TaiGen through various state entities, while YFY Group (永豐餘集團) holds 35.76 percent, with other shareholders, including Shin Kong Life Insurance (新光人壽) and Cathay Life Insurance (國泰人壽) holding the remainder, according to TaiGen.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
TRANSFORMATION: Taiwan is now home to the largest Google hardware research and development center outside of the US, thanks to the nation’s economic policies President Tsai Ing-wen (蔡英文) yesterday attended an event marking the opening of Google’s second hardware research and development (R&D) office in Taiwan, which was held at New Taipei City’s Banciao District (板橋). This signals Taiwan’s transformation into the world’s largest Google hardware research and development center outside of the US, validating the nation’s economic policy in the past eight years, she said. The “five plus two” innovative industries policy, “six core strategic industries” initiative and infrastructure projects have grown the national industry and established resilient supply chains that withstood the COVID-19 pandemic, Tsai said. Taiwan has improved investment conditions of the domestic economy
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
MAJOR BENEFICIARY: The company benefits from TSMC’s advanced packaging scarcity, given robust demand for Nvidia AI chips, analysts said ASE Technology Holding Co (ASE, 日月光投控), the world’s biggest chip packaging and testing service provider, yesterday said it is raising its equipment capital expenditure budget by 10 percent this year to expand leading-edge and advanced packing and testing capacity amid strong artificial intelligence (AI) and high-performance computing chip demand. This is on top of the 40 to 50 percent annual increase in its capital spending budget to more than the US$1.7 billion to announced in February. About half of the equipment capital expenditure would be spent on leading-edge and advanced packaging and testing technology, the company said. ASE is considered by analysts